Evidence map›Paper›PMID 16537452›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II.

François Foulquier, Eliza Vasile, Els Schollen, Nico Callewaert, Tim Raemaekers, Dulce Quelhas, Jaak Jaeken, Philippa Mills, Bryan Winchester, Monty Krieger and 2 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 3 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Putative role of TMEM165 in congenital cardiomyopathies.Frontiers in molecular neuroscience · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Towards understanding the extensive diversity of protein N-glycan structures in eukaryotes.Biological reviews of the Cambridge Philosophical Society · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

François FoulquierLaboratory for Molecular Diagnostics, Center for Human Genetics, Gasthuisberg, Belgium.
Eliza Vasile
Els Schollen
Nico Callewaert
Tim Raemaekers
Dulce Quelhas
Jaak Jaeken
Philippa Mills
Bryan Winchester
Monty Krieger
Wim Annaert
Gert Matthijs
KU Leuven · BEMassachusetts Institute of Technology · USUniversity College London · GBCentro de Genética Clínica · PTVlaams Instituut voor Biotechnologie · BE

Funding

GENES CONTROLLING LDL RECEPTOR STRUCTURE AND FUNCTIONR01GM059115 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KRIEGER, MONTY · 2000 to 2003
$1.1M
NIGMS NIH HHS GM59115NIGMS NIH HHS R01 GM059115
6 · The paper itself

Abstract

The conserved oligomeric Golgi (COG) complex is a heterooctameric complex that regulates intraGolgi trafficking and the integrity of the Golgi compartment in eukaryotic cells. Here, we describe a patient with a mild form of congenital disorder of glycosylation type II (CDG-II) that is caused by a deficiency in the Cog1 subunit of the complex. This patient has a defect in both N- and O-glycosylation. Mass spectrometric analysis of the structures of the N-linked glycans released from glycoproteins from the patient's serum revealed a reduction in sialic acid and galactose residues. Peanut agglutinin (PNA) lectin staining revealed a decrease in sialic acids on core 1 mucin type O-glycans, indicating a combined defect in N- and O-glycosylation. Sequence analysis of the COG1 cDNA and gene identified a homozygous insertion of a single nucleotide (2659-2660insC), which is predicted to lead to a premature translation stop and truncation of the C terminus of the Cog1 protein by 80 amino acids. This mutation destabilizes several other COG subunits and alters their subcellular localization and hence the overall integrity of the COG complex. This results in reduced levels and/or altered Golgi localization of alpha-mannosidase II and beta-1,4 galactosyltransferase I, which links it to the glycosylation deficiency. Transfection of primary fibroblasts of this patient with the full length hemagglutinin-tagged Cog1 indeed restored beta-1,4 galactosyltransferase Golgi localization. We propose naming this disorder CDG-II/Cog1, or CDG-II caused by Cog1 deficiency.

Indexed as

Adaptor Proteins, Vesicular TransportBase SequenceBlood ProteinsCarbohydrate Metabolism, Inborn ErrorsCarrier ProteinsDNADNA Mutational AnalysisFemaleGlycoproteinsGlycosylationGolgi ApparatusHumansInfantInfant, NewbornIn Vitro TechniquesMembrane ProteinsAdaptor Proteins, Vesicular TransportBlood ProteinsCarrier ProteinsCOG1 protein, humanDNAGlycoproteinsMembrane ProteinsPolysaccharidesProtein Subunits

Identifiers

PMID16537452
PMCPMC1450151
OpenAlexW2036557000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.